跳至主要内容
临床试验/NCT04242758
NCT04242758Unknown4 期

Exploring the Association Between Phthalates Exposure, Measured Through Their Urinary Metabolites, and Renal Function Impairment in Individuals With TYpe 2 Diabetes - SGLT2 Subprotocol

University of Pisa1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2019年6月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
30
试验地点
1
主要终点
Urinary Phthalates concentration

研究概览

简要总结

In this open clinical trial, 30 subjects with inadequately controlled T2D and eligible, as per good clinical practice, for therapy with SGLT-2 inhibitor, will be randomized to receive a SGLT-2 inhibitor vs other oral-antidiabetic drugs (OADs) therapy for 3 months. Measures will be performed at baseline, after 2 days, after one month and at the end of the study protocol, as per good clinical practice

详细描述

  • Total concentrations of MEHP, MEOHP and MEHHP will be quantified, in the laboratories of the Institute of Clinical Physiology, National Research Council, Pisa, in a spot morning urine sample by ultra-HPLC coupled with electrospray ionization/quadrupole time-of-flight mass spectrometry (Agilent UHPLC 1290 infinity coupled to an Agilent 6540 MS-QTOF, Santa Clara, CA) using stable isotope labeled substrates, i.e. MEHP (ring-1,2-13C2, dicarboxyl-13C2), MEHHP, MEHHP 13C4, MEOHP and MEOHP 13C4 that will be purchased from Cambridge Isotope Laboratories (Tewksbury, MA).
  • Urinary creatinine concentrations will be measured to adjust urinary concentrations of DEHP metabolite (Beckman Coulter AU400, Brea, CA), thus minimizing the influence of urine volume.
  • Serum and urinary inflammatory markers and adipocytokines will be quantitatively determined using sandwich enzyme-linked immunosorbent assays kits according to the manufacturer's instructions. Optical density will be measured using a microplate reader.
  • Serum and urinary markers of oxidative stress will be measured by gold standard techniques. In detail, MDA will be quantified by TBARS reactive substances measured by optical density; GSH-Px by a specific assay kit according to the manufacturer's instruction; SOD activity will be determined using a specific SOD kit; urinary 8-isoprostane concentration will be measured by a specific affinity sorbent. (Cayman Chemical, Ann Harbor, MI, USA) according to the manufacturer's instructions.
  • To analyze mitochondrial DNA we will apply a triplex design previously reported to amplify mitochondria loci located within the MinorArc and MajorArc, respectively. To assess nuclear DNA, we will use RNase P Copy Number Reference.
  • The phthalates-free diet will be self-administered by the individuals under intervention, following a set of instruction and rules provided by the physicians based on the current literature data.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals of both sex;
  • Age between 18 and 85 years;
  • T2D duration > 6 months
  • BMI ≤ 40 Kg/m2,
  • HbA1c > 48 mmol/mol
  • Eligible for SGLT-2i therapy
  • Exclusion criteria
  • age >85 years,
  • eGFR <60 ml/min/1.73 m2,
  • occurring acute complications

排除标准

  • 未提供

研究组 & 干预措施

Dapaglifozin

Experimental

People undergoing SGLT2i (Dapaglifozin) therapy

干预措施: Dapagliflozin 10 MG (Drug)

Hydrochlorothiazide

Experimental

People undergoing thiazide (Hydrochlorothiazide) therapy

干预措施: Hydrochlorothiazide 12.5mg (Drug)

结局指标

主要结局

Urinary Phthalates concentration

时间窗: Changes between baseline and 3 month

Exposure to phthalates assessed through urinary excretion spot and 24-hours

次要结局

  • Renal function(1 and 3 months)
  • Glycated Haemoglobin(1 and 3 months)
  • Albumin excretion(1 and 3 months)
  • Macrovascular events(1 and 3 months)
  • Fasting glucose(1 and 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anna Solini

Associate Professor

University of Pisa

研究点 (1)

Loading locations...

相似试验

Phthalates Exposure in Type 2 Diabetic Patients and... | 临床试验